CRIS

Conviction 72HealthcareScan · Mon, Jul 20, 2026

Bearish marubozu

CRIS$4.51-2.59%

ResistanceSupportVol 14

Vol MA14 1.47M

Apr 20May 6May 26Jun 11Jul 1Jul 20

CURIS INCBiological Products, (No Diagnostic Substances)www.curis.com ↗

Price4.51

Change-2.59%

Gap-1.84%

Rel volume0.00×

Avg volume8.78M

Avg $ vol3.39M

SMA 202.89

SMA 501.45

SMA 2001.15

Price vs 50+211.72%

Price vs 200+292.77%

MA stackbullish

50/200 crossgolden · 4d

Supertrendup · 4.10

RSI (14)69

MACD hist0.11

MACD cross—

Stoch %K / %D65 / 68

ADX (14)38

+DI / −DI45 / 16

RSI divergence—

MACD divergence—

ATR %+11.94%

ADR %22.19%

52w high5.94

52w low0.2058

From 52w high-24.07%

Above 52w low+2091.45%

New 52w highNo

SqueezeOff

Bollinger width317.09%

%B0.68

Donchian pos66.00%

Donchian high6.74

Donchian low0.1806

AVWAP (52w high)5.20

vs AVWAP high-13.23%

AVWAP (52w low)0.3677

vs AVWAP low+1126.69%

OBV trendUp

Chaikin MF (20)0.37

Today vs 20d0.00×

Avg vol (14d)1.47M

Avg vol (20d)8.78M

Avg $ vol (20d)3.39M

Market cap175.79M

RS 3m (vs SPY)+677.35%

RS 6m (vs SPY)+404.22%

RS line new highNo

Trend template6/8

Technical rank95.0

1 week-5.05%

1 month+1010.84%

3 months+647.93%

6 months+374.79%

1 year+145.11%

YTD+358.80%

P/E-23.19

P/B13.83

P/S18.62

P/FCF-6.46

EPS-0.5800

Div yield—

ROE-59.67%

ROA-25.54%

Debt/Eq0.00

Current1.11

EV/EBITDA-28.78

Gross margin—

Net margin-80.29%

Rev growth-13.43%

EPS growth82.53%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value160.79M

Revenue0

Net income-24.2M

Gross profit—

Free cash flow-27.2M

IndustryBiological Products, (No Diagnostic Substances)

ExchangeNasdaq

Shares out38.98M

Employees24

ListedTue, Aug 1, 2000

Free float12.66M

Float %92.2%

Short interest3.52M

Days to cover0.2d

Short volume46.9%

Squeeze score46 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$25.00 vs −$3.80

Last surprise-557.9% miss

Setup gradeB

Conviction72 / 100

Pattern quality—

Tech rank95.0 / 100

Group rank—

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBearish marubozu

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CRIS

All disclosures →

No recent disclosed trades by Congress in CRIS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CRIS · 8 buys

Insider	Side	Shares	Value	Traded	Filed
GREENACRE MARTYN D Director · Non Qualified Stock Option · 2026-07-07	Grant	6.8K	$36K	2026-07-07	2026-07-09
Borgman Anne Elizabeth Director · Non Qualified Stock Option · 2026-07-07	Grant	6.8K	$36K	2026-07-07	2026-07-09
Dentzer James E President & CEO · Employee stock option (right to buy) · 2026-07-07	Grant	110.09K	$582K	2026-07-07	2026-07-09
Zung Jonathan B. CDO · Employee stock option (right to buy) · 2026-07-07	Grant	48.28K	$255K	2026-07-07	2026-07-09
Duvall Diantha CFO · Employee stock option (right to buy) · 2026-07-07	Grant	48.28K	$255K	2026-07-07	2026-07-09
Hohneker John Director · Non Qualified Stock Option · 2026-07-07	Grant	6.8K	$36K	2026-07-07	2026-07-09
KAITIN KENNETH I Director · Non Qualified Stock Option · 2026-07-07	Grant	6.8K	$36K	2026-07-07	2026-07-09
Rubin Marc Director · Non Qualified Stock Option · 2026-07-07	Grant	6.8K	$36K	2026-07-07	2026-07-09

SEC filings

EDGAR filings in CRIS · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.